Trial intelligence / Profile preview

Primovist Hepatic Uptake and OATP Genotypes

NCT01420211Phase 2Completed

Sponsor
Universitätsklinikum Greifswald
Start
Oct 2006
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of gadoxetate disodium in liver disease, sponsored by Universitätsklinikum Greifswald. Started Oct 2006; status: completed.

02

Drugs

gadoxetate disodium
03

Conditions

liver disease

Beyond the preview

Go deeper on NCT01420211.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01420211.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call